7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Can the Cyclicals Continue to Outperform?

by Neena Mishra

August 23, 2012 | Comments : 3 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Housing markets as well as the labor markets are now showing signs of slow improvement and the fears of the domestic economy slipping into recession have subsided. Further many statements from the Euro-zone policymakers regarding their resolve to do “whatever it takes" to preserve the monetary union, have boosted the investor sentiment.

As a result, the market indexes are now near their highest levels in the last four years. The following table shows the sector-wise performance using the SPDR ETFs:

Sector

Ticker

YTD Return (%)

1 Month Return (%)

3 Month Return (%)

1 Year Return (%)

SPDR-Technology

XLK

20.35

7.55

9.67

30.51

SPDR-Consumer Discretionary

XLY

16.12

5.10

4.52

27.74

SPDR-Financials

XLF

16.92

6.59

8.03

22.90

SPDR-Industrial

XLI

9.16

5.32

4.78

21.70

SPDR-Healthcare

XLV

10.87

1.75

5.34

20.11

SPDR-Consumer Staples

XLP

9.48

2.39

4.86

17.59

SPDR-Utilities

XLU

2.36

-1.58

3.28

11.98

SPDR-Energy

XLE

4.67

6.21

10.57

10.37

SPDR-Materials

XLB

9.01

4.76

7.00

10.23

Technology sector is a big winner this year (thanks to Apple!), followed by consumer discretionary and financials.

Looking at the one -month returns, technology, financials, energy, industrial and consumer discretionary sectors outperformed the broader market. On the other hand defensive sectors like utilities, healthcare and consumer staples lagged behind.

Recent outperformance by the economically sensitive or so-called 'risk-on' sectors indicates that the investors are now willing to take on more risk. These sectors had underperformed the defensive sectors earlier when the fears of a global economic collapse had driven the investors to the ‘safer’ sectors.

However, there are still many factors that will keep the market volatile through the end of the year. Further, global economy is not improving substantially anytime soon. Thus, a sustainable rebound by the cyclical sectors appears to be in doubt.

Do you think that the cyclical sectors can continue their recent outperformance through the end of this year?

Email Print Share Rate Pos Rate Neg

Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest. Today, you can see them free.

Close This Panel X
Read/Post Comments (3) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.